Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meenakshi Devidas

Showing results (21-30 of 297) with videos related to

Pageof 30
Sort By:
Journal of Pediatric Hematology/Oncology|June 7, 2007
Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology GroupWanda L Salzer, Meenakshi Devidas, Jonathan J Shuster, et al.
Journal of Vascular Surgery|April 5, 2002
Functional outcome after thoracoabdominal aortic aneurysm repairJohn E Rectenwald, Thomas S Huber, Tomas D Martin, et al.
Leukemia & Lymphoma|April 10, 2008
Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable geneticsNaveed I Khan, Adam Cisterne, Meenakshi Devidas, et al.
Pediatric Blood & Cancer|July 25, 2023
Children's Oncology Group blueprint for research: Acute lymphoblastic leukemiaElizabeth A Raetz, Deepa Bhojwani, Meenakshi Devidas, et al.
Pediatric Blood & Cancer|July 12, 2005
Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296Stuart S Winter, Mark T Holdsworth, Meenakshi Devidas, et al.
Pediatric Blood & Cancer|February 10, 2015
Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: a report from the Children's Oncology GroupSusan J Lindemulder, Linda C Stork, Bruce Bostrom, et al.
Pediatric Blood & Cancer|May 28, 2011
Germline genetic variation and treatment response on CCG-1891Dana M Sepe, Thomas McWilliams, Jinbo Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology groupStephen P Hunger, Xiaomin Lu, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2012
Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology GroupKimberly P Dunsmore, Meenakshi Devidas, Stephen B Linda, et al.
Pediatric Blood & Cancer|September 2, 2014
Family life events in the first year of acute lymphoblastic leukemia therapy: a children's oncology group reportSamantha Lau, Xiaomin Lu, Lyn Balsamo, et al.
Pageof 30

Showing results (21-30 of 297) with videos related to

Sort By:
Pageof 30
Journal of Pediatric Hematology/Oncology|June 7, 2007
Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology GroupWanda L Salzer, Meenakshi Devidas, Jonathan J Shuster, et al.
Journal of Vascular Surgery|April 5, 2002
Functional outcome after thoracoabdominal aortic aneurysm repairJohn E Rectenwald, Thomas S Huber, Tomas D Martin, et al.
Leukemia & Lymphoma|April 10, 2008
Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable geneticsNaveed I Khan, Adam Cisterne, Meenakshi Devidas, et al.
Pediatric Blood & Cancer|July 25, 2023
Children's Oncology Group blueprint for research: Acute lymphoblastic leukemiaElizabeth A Raetz, Deepa Bhojwani, Meenakshi Devidas, et al.
Pediatric Blood & Cancer|July 12, 2005
Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296Stuart S Winter, Mark T Holdsworth, Meenakshi Devidas, et al.
Pediatric Blood & Cancer|February 10, 2015
Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: a report from the Children's Oncology GroupSusan J Lindemulder, Linda C Stork, Bruce Bostrom, et al.
Pediatric Blood & Cancer|May 28, 2011
Germline genetic variation and treatment response on CCG-1891Dana M Sepe, Thomas McWilliams, Jinbo Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology groupStephen P Hunger, Xiaomin Lu, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2012
Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology GroupKimberly P Dunsmore, Meenakshi Devidas, Stephen B Linda, et al.
Pediatric Blood & Cancer|September 2, 2014
Family life events in the first year of acute lymphoblastic leukemia therapy: a children's oncology group reportSamantha Lau, Xiaomin Lu, Lyn Balsamo, et al.
Pageof 30